ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 2507

What Is The Risk Of Having a Total Hip Or Knee Replacement for Patients With Lupus?

Sandeep Mukherjee1, David Culliford2, Nigel K. Arden3 and Christopher J. Edwards1, 1NIHR Wellcome Trust Clinical Research Facility, University Hospital Southampton NHS Foundation Trust, Southampton, United Kingdom, 2Faculty of Medicine, University of Southampton, Southampton, United Kingdom, 3NDORMS; MRC Lifecourse Epidemiology Unit, Oxford NIHR Musculoskeletal Biomedical Research Unit, University of Oxford, Oxford, United Kingdom

Meeting: 2013 ACR/ARHP Annual Meeting

Keywords: Hip, Knee, Lupus and arthroplasty

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Title: Systemic Lupus Erythematosus-Clinical Aspects III: Biomarkers, Quality of Life and Disease Indicators, Late Complications

Session Type: Abstract Submissions (ACR)

Background/Purpose:

Individuals with systemic lupus erythematosus (SLE) frequently have arthralgia, but joint damage leading to surgery is thought to be less common. In addition to inflammatory damage, other reasons like avascular necrosis (AVN), often associated with steroid use and antiphospholipid syndrome (APS), may increase the likelihood of large joint failure.  Demonstrating the risk of joint replacement in lupus patients and factors contributing to this may allow preventative action.

Methods:

We performed a retrospective matched case control study of all total hip replacements (THR) and total knee replacements (TKR) between 1991 and 2011 recorded in the General Practice Research Database (GPRD), a primary care database containing data on approximately 3.6 million patients from over 480 primary care practices. There were two controls for each case of primary THR or TKR, matched for age, sex and GP practice location (a proxy for socio-economic status). The odds of having THR or TKR for individuals with SLE were compared with those without lupus through Chi-squared analysis followed by conditional logistic regression taking account of the matching. Individuals with inflammatory arthritis due to any other cause were excluded and results adjusted for steroid use and APS.

Results:

During the 20-year study period 63162 patients had a primary THR (123624 matched controls). Within this total sample size of 186786, 122 individuals with a previous diagnosis of SLE had a THR performed (see table). After excluding those who had an inflammatory arthritis other than lupus, there remained 181464 individuals without lupus and 60167 of them underwent primary THR (see table). During the same period 54276 individuals had a primary TKR (106302 matched controls). Again out of this new total sample size of 160578, 124 individuals with a diagnosis of SLE had a TKR performed (see table). After exclusions for other inflammatory arthritis, there were 154850 individuals without lupus, 50658 of whom underwent primary TKR (see table). Overall, for individuals with a previous diagnosis of SLE, the unadjusted odds ratio (OR) of having a THR was 1.43 (95% confidence interval (CI): 1.13 to 1.81, p=0.0030) over those without lupus and that for having a TKR was 2.54 (95% CI: 1.94 to 3.33, p<0.0001). However, after adjustment the OR were 1.20 (95% CI: 0.94 to 1.52, p=0.1441) and 1.91 (95% CI: 1.44 to 2.53, p<0.0001) respectively.

Conclusion:

Patients with lupus who have a THR or TKR tend to be younger than their peers without lupus. In addition, they appear to have a significantly increased risk of TKR but the increased risk of THR does not remain after adjustment for anti-phospholipid syndrome and steroid use.

THR THR TKR TKR
Without Lupus

With Lupus

Without Lupus With Lupus
Number of individuals    60167   122   50658   124

Mean Age (years)

   69.5

  65.7

  70.4   66.3
Male:Female    1:1.6   1:10   1:1.3

  1:8             

OR unadjusted

 1.43             

(p = 0.0030)

  2.54

(p = <0.0001)

OR adjusted

  1.20

(p = 0.1441)

  1.91

(p = <0.0001)


Disclosure:

S. Mukherjee,
None;

D. Culliford,
None;

N. K. Arden,
None;

C. J. Edwards,
None.

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2013 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/what-is-the-risk-of-having-a-total-hip-or-knee-replacement-for-patients-with-lupus/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology